Here, we speculate that an increased expression of IL-33 in the gout patients might due to a cause of self-negative regulation, which inhibits the development of MSU-induced inflammation, while the increased amount of IL-33 expression was inadequate to induce a potent protective effect to reduce the development of gout. Here, IL33 is linked to gout.